Is Regorafenib a chemotherapy drug?

Regorafenib(Regorafenib)Although it is used to treat some types of cancer, it is not a chemotherapy drug in the traditional sense. It is a multi-target inhibitor that works by inhibiting tumor cell proliferation and angiogenesis. Traditional chemotherapy drugs mainly kill cancer cells by interfering with their DNA replication or cell division. Regorafenib interferes with tumor growth and metastasis by inhibiting key molecules in multiple signaling pathways.

Regofeniband is not a typical chemotherapy drug, but it is often used as a further treatment for patients who have already received chemotherapy or targeted therapy and whose disease is still progressing. It can be used as an additional treatment option to control the growth of tumors and prolong the survival time of patients,But everyone’s body is different, and their drug effects and drug resistance reactions are also different. If you experience any discomfort during treatment with regorafenib, you should inform your doctor in time for adjustments.

RegofenibThe original drug has been launched in China and has entered the scope of Class B medical insurance. Reimbursement is limited to patients who meet the indications. SpecificationThe price of each box of 40mg*28 tablets is around RMB 5,000. The reimbursement ratio is different in different regions, and the price after reimbursement is different. The Turkish version of regorafeniboriginal drug specifications 40mg*28 tablets sold overseas is priced around RMB 6,400 per box (the price may fluctuate due to exchange rates). There are also generic regorafenib drugs produced in other countries, and their drug ingredients are basically the same as those of the original drug. The price of a box of 40mg*90 tablets produced by a Bangladesh pharmaceutical factory is around 2,900 yuan (the price may fluctuate due to exchange rates).